Please click here to view this emailer online
HHM Global
Click here to subscribe to our newsletter
Medical Fair Asia 2018
White Paper
Xcenda and Family Reach Collaborate in order to solve cancer related financial crisis

Xcenda and Family Reach Collaborate in order to solve cancer related financial crisis

Xcenda and Family Reach collaborate to reach out to cancer survivors and patients struggling with finances

READ MORE
Top Latest Press Releases
CAR T-Cell Therapy Provides High Remission Rate in Paediatric and Young Adult Patients with Relapsed or Refractory B-Cell ALL

CAR T-Cell Therapy Provides High Remission Rate in Paediatric and Young Adult Patients with Relapsed or Refractory B-Cell ALL

Anti-CD19 CAR T-cell therapy, tisagenlecleucel produced high remission rates and durable remissions without additional therapy in high-risk paediatric and young adult patients...

READ MORE

Price cap on cardiac stents stifling innovation, harming patients: Manufacturers

Medical device manufacturers and related associations assembled at the NAPP Authority to argue against the current price caps and propose more viable solutions.

READ MORE

Philips debuts fully integrated suite of enhanced patient monitoring solutions in U.S. market

Royal Philips , a global leader in health technology announced the launch of its next-generation Patient Monitoring solution in the U.S.

READ MORE
Top Latest News
Malaysia’s IHH, Temasek eye majority stake in Medanta

Brain Disconnections May Contribute To Parkinson's Hallucinations

Researchers have found that disconnections of brain areas involved in attention and visual processing may contribute to visual hallucinations in individuals with Parkinson's disease, according to a new study published online in the journal Radiology.

READ MORE

Combining MRI And Optical Microscopy Promising For Brain Research

Functional MRI reveals changes in blood-oxygen levels in different parts of the brain, but the data show nothing about what is actually happening in and between brain cells information needed to better understand brain...

READ MORE

Delay in adjuvant chemotherapy and survival advantage in stage III colon cancer

Adjuvant chemotherapy following resection is the standard of care for stage III colon cancer, yet many patients omit chemotherapy.

READ MORE


Advertising:

sunnyroger@hhmglobal.com
Phone: + 91 84476 12124

If you like to receive our latest Media Pack 2018 / Editorial Calender please click here

For the latest visit: www.hhmglobal.com